Midwest Positron Technology

Midwest Positron Technology was a radiopharmaceutical company specializing in the production and distribution of Positron Emission Tomography (PET) imaging agents. The company operated cyclotron facilities to manufacture high-quality diagnostic tracers, primarily Fludeoxyglucose F18 (FDG), for use in clinical settings. Serving the Midwestern United States, it provided critical imaging supplies to hospitals and diagnostic centers for the detection and monitoring of cancer, heart disease, and brain disorders. In 2015, the company was acquired by Zevacor Pharma, and its operations were subsequently integrated into the SOFIE radiopharmaceutical network. The company played a significant role in regional molecular imaging infrastructure before the consolidation of the radiopharmacy market.